After being successfully treated for ER+ breast cancer, Zoë dreams of having a baby. But the hormonal treatment, which would take about 5 to 10 years, prevents her from becoming a mom.
Watch her testimonial video and learn how you can make a BIG difference.
More than anyone else, you know how much research is important and that you are part of the solution.
Approximately 1 in 3 of all breast cancers will metastasise, meaning the cancer has spread to other parts of the body. Just as a GPS guidance system helps you...
Results of the MINDACT clinical trial were presented by Dr Piccart at the AACR Annual Meeting 2016 (New Orleans, USA) on 18 April. The aim of MINDACT was to evaluate the added value of a test of 70 genes (Mammaprint®) to the traditional method of assessing the likelihood of breast cancer recurrence for women with node-negative and 1-to-3 node positive breast cancer. The study results will help oncologists decide which of these patients will be able to safely avoid chemotherapy and the side effects that come with it.
Checkpoint inhibitors make headlines with promising new data in cancer treatment on an almost daily basis, especially in melanoma and lung cancer. But what role are they - and other forms of immunotherapy - expected to play in breast cancer and why does progress appear to be slower than for some other tumours?
Several of BIG's trials are considered to be landmark, introducing particularly innovative designs, contributing to significant breakthroughs, or paving the way towards more personalised treatment of the disease.
Finding a cure for breast cancer is one of the biggest challenges faced by researchers from around the world.
Significant progress has been made to improve both the chances of survival and the quality of life of women affected by the disease. However, breast cancer remains the second most common cancer in the world and is still responsible for too many deaths annually.
By bringing together the top breast cancer experts from around the world to conduct innovative research, BIG has the global reach and expertise required to find a cure. We need to support such critical research to give hope to women affected by this devastating disease, and their families.
HER MAJESTY THE QUEEN OF THE BELGIANS